Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Handbook of Clinical Neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-444-64076-5.00039-9PMID 29478603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

  2017cited by this paper
• Single domain antibody fragments reverse cognitive function deficits and restore memory in aged beagles

  2017cited by this paper
• Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

  2017cited by this paper
• Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.

  2016cited by this paper
• NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

  2016cited by this paper
• CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

  2016cited by this paper
• C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD.

  2016cited by this paper
• Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians

  2016cited by this paper
• Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

  2016cited by this paper
• C9ORF72-ALS/FTD: Transgenic Mice Make a Come-BAC.

  2016cited by this paper
• Screening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral Sclerosis

  2016cited by this paper
• Optineurin: The autophagy connection.

  2016cited by this paper
• Presymptomatic ALS genetic counseling and testing

  2016cited by this paper
• Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Heritability of Amyotrophic Lateral Sclerosis: Insights From Disparate Numbers.

  2015cited by this paper
• C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.

  2015cited by this paper
• Emerging mechanisms of molecular pathology in ALS.

  2015cited by this paper
• Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia

  2015cited by this paper
• From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.

  2015cited by this paper
• RNA-targeted Therapeutics for ALS

  2015cited by this paper
• C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits

  2015cited by this paper
• Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.

  2015cited by this paper
• Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes

  2015cited by this paper
• Re-evaluation of the phenotype caused by the common MATR3 p.Ser85Cys mutation in a new family

  2015cited by this paper
• Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.

  2015cited by this paper
• Induced pluripotent stem cells from ALS patients for disease modeling.

  2015cited by this paper
• Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.

  2015cited by this paper
• The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter

  2015cited by this paper
• Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

  2015cited by this paper
• Genotype-Property Patient-Phenotype Relations Suggest that Proteome Exhaustion Can Cause Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era

  2015cited by this paper
• Genome-wide analysis of the heritability of amyotrophic lateral sclerosis.

  2014cited by this paper
• Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes

  2014cited by this paper
• The phenotypic variability of amyotrophic lateral sclerosis

  2014cited by this paper
• Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation.

  2014cited by this paper
• Analysis of Mutant SOD1 Electrophoretic Mobility by Blue Native Gel Electrophoresis; Evidence for Soluble Multimeric Assemblies

  2014cited by this paper
• A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.

  2014cited by this paper
• PFN1 mutations are also rare in the Catalan population with amyotrophic lateral sclerosis

  2014cited by this paper
• Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models

  2014cited by this paper
• Reply: Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis.

  2014cited by this paper
• Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.

  2014cited by this paper
• Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones.

  2014cited by this paper
• The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype

  2014cited by this paper
• Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.

  2014cited by this paper
• Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress

  2014cited by this paper
• Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research

  2014cited by this paper
• CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

  2014cited by this paper
• Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease.

  2014cited by this paper
• Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders

  2014cited by this paper
• Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis

  2014cited by this paper
• Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases

  2014cited by this paper
• Phenotype of matrin‐3–related distal myopathy in 16 German patients

  2014cited by this paper
• Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?

  2014cited by this paper
• Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

  2014cited by this paper
• Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms

  2014cited by this paper
• Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.

  2014cited by this paper
• RNA metabolism in ALS: When normal processes become pathological

  2014cited by this paper
• Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease

  2014cited by this paper
• C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome‐wide meta‐analysis

  2014cited by this paper
• Patient-Specific Induced Pluripotent Stem Cells for SOD1-Associated Amyotrophic Lateral Sclerosis Pathogenesis Studies

  2014cited by this paper
• ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.

  2013cited by this paper
• RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

  2013cited by this paper
• Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain

  2013cited by this paper
• A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany.

  2013cited by this paper
• Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia

  2013cited by this paper
• Small Peptides against the Mutant SOD1/Bcl-2 Toxic Mitochondrial Complex Restore Mitochondrial Function and Cell Viability in Mutant SOD1-Mediated ALS

  2013cited by this paper
• Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS

  2013cited by this paper
• TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update

  2013cited by this paper
• SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis.

  2013cited by this paper
• Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology

  2013cited by this paper
• Mutation analysis of PFN1 in familial amyotrophic lateral sclerosis patients.

  2013cited by this paper
• Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion.

  2013cited by this paper
• Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

  2013cited by this paper
• ER Dysfunction and Protein Folding Stress in ALS

  2013cited by this paper
• State of play in amyotrophic lateral sclerosis genetics

  2013cited by this paper
• Mutation analysis and immunopathological studies of PFN1 in familial and sporadic amyotrophic lateral sclerosis.

  2013cited by this paper
• Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France.

  2013cited by this paper
• Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

  2013cited by this paper
• An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.

  2013cited by this paper
• Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia.

  2013cited by this paper
• A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts.

  2013cited by this paper
• Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72

  2013cited by this paper
• PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis.

  2013cited by this paper
• Cognitive changes predict functional decline in ALS

  2013cited by this paper
• Inhibition of Fast Axonal Transport by Pathogenic SOD1 Involves Activation of p38 MAP Kinase

  2013cited by this paper
• Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

  2013cited by this paper
• Stress granules as crucibles of ALS pathogenesis

  2013cited by this paper
• Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing

  2013cited by this paper
• ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.

  2013cited by this paper
• Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS.

  2013cited by this paper
• Exome sequencing to identify de novo mutations in sporadic ALS trios

  2013cited by this paper
• Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.

  2013cited by this paper
• The changing scene of amyotrophic lateral sclerosis

  2013cited by this paper
• Using Reference Databases of Genetic Variation to Evaluate the Potential Pathogenicity of Candidate Disease Variants

  2013cited by this paper
• Genetic counselling in ALS: facts, uncertainties and clinical suggestions

  2013cited by this paper
• Rodent models of amyotrophic lateral sclerosis.

  2013cited by this paper
• Mutations in the profilin 1 gene are not common in amyotrophic lateral sclerosis of Chinese origin.

  2013cited by this paper
• Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis

  2013cited by this paper
• The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons

  2013cited by this paper
• The epidemiology of ALS: a conspiracy of genes, environment and time

  2013cited by this paper

• Brain-derived extracellular vesicles potentially mediate crosstalk with peripheral organs in neurodegenerative diseases

  2026cites this paper
• A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis

  2025cites this paper
• The Role of Non-Coding RNAs in ALS

  2025cites this paper
• Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients

  2025cites this paper
• Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study

  2025cites this paper
• Hidden players in the metabolic vulnerabilities of amyotrophic lateral sclerosis.

  2025cites this paper
• Validation in Drosophila of the in silico predicted clomipramine as repurposable for SOD1-ALS.

  2025cites this paper
• ‘I want to be generous, but I only have limited energy’: a qualitative study of amyotrophic lateral sclerosis patients’ preferences for clinical trials participation

  2025cites this paper
• Role of lipocalin-2 in amyotrophic lateral sclerosis

  2025cites this paper
• Combinatorial network of transcriptional and post-transcriptional regulation in amyotrophic lateral sclerosis

  2024cites this paper
• Association of UNC13A with increased amyotrophic lateral sclerosis risk, bulbar onset, and lower motor neuron involvement in a Norwegian ALS cohort

  2024cites this paper
• A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach

  2024cites this paper
• Epigenetic age acceleration is associated with occupational exposures, sex, and survival in amyotrophic lateral sclerosis

  2024cites this paper
• Amyotrophic lateral sclerosis caused by the C9orf72 expansion in Norway – prevalence, ancestry, clinical characteristics and sociodemographic status

  2024cites this paper
• The ALS-associated KIF5A P986L variant is not pathogenic for Drosophila motoneurons

  2024cites this paper
• Amyotrophic Lateral Sclerosis (ALS): An Overview of Genetic and Metabolic Signaling Mechanisms.

  2024cites this paper
• Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation

  2024cites this paper
• Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis

  2024cites this paper
• The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis

  2023cites this paper
• Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders

  2023cites this paper
• Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials

  2022cites this paper
• Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts

  2022cites this paper
• Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.

  2022cites this paper
• Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.

  2022cites this paper
• Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study

  2022cites this paper
• Amyotrophic lateral sclerosis

  2022cites this paper
• The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis

  2022influential citation
• A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G

  2022cites this paper
• Amyotrophic lateral sclerosis

  2022cites this paper
• Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis

  2021cites this paper
• Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia

  2021cites this paper
• Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2021cites this paper
• Manifold learning for amyotrophic lateral sclerosis functional loss assessment

  2020cites this paper
• A Systematic Review of Genotype–Phenotype Correlation across Cohorts Having Causal Mutations of Different Genes in ALS

  2020cites this paper
• Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: how common are common mutations in ALS genes?

  2020cites this paper
• Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis

  2020cites this paper
• Variable Selection with Multiply-Imputed Datasets: Choosing Between Stacked and Grouped Methods

  2020cites this paper
• Dysregulated biodynamics in metabolic attractor systems precede the emergence of amyotrophic lateral sclerosis

  2020cites this paper
• Clinical and genetic features of patients with amyotrophic lateral sclerosis in southern China

  2020cites this paper
• Untargeted metabolomics yields insight into ALS disease mechanisms

  2020cites this paper
• Big data of clinical manifestations combined with neuroelectrophysiologic features in the early diagnosis of motor neuron disease

  2019cites this paper
• Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls

  2019cites this paper
• Big data of clinical manifestations combined with neuroelectrophysiologic features in the early diagnosis of motor neuron disease

  2019influential citation
• A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis

  2019cites this paper
• Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials

  2019cites this paper
• Emerging insights into the complex genetics and pathophysiology of ALS

  year unknowncites this paper
• Amyotrophic Lateral Sclerosis 1 Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis

  year unknowncites this paper